SCHEMBL16625601

SCHEMBL16625601

Cc1ccc(NC(=O)c2cnccc2NCc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
KDR P35968 5/20 0.58
KDM4C Q9H3R0 2/20 0.54
KDM4E B2RXH2 1/20 0.54
KDM6B O15054 1/20 0.54
KDM4A O75164 1/20 0.54
KDM4D Q6B0I6 1/20 0.54
FLT1 P17948 5/20 0.53
MAPT P10636 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
NAMPT P43490 2/20 0.48
HTT P42858 1/20 0.48
KDM5B Q9UGL1 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KIT P10721 2/20 0.47
BRAF P15056 1/20 0.47
CYP3A4 P08684 1/20 0.47
ABL1 P00519 1/20 0.47
EGFR P00533 1/20 0.47
CSF1R P07333 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16625615 0.91 KDM4C (0.64) ALDH1A1KDRKDM4CKDM4EKDM6B
SCHEMBL15528663 0.85 KMT2A (0.54) ALDH1A1KDRKDM4EMAPTNPSR1
SCHEMBL4979677 0.85 KDR (0.71) ALDH1A1KDRFLT1MAPTNAMPT
SCHEMBL1585595 0.80 KDM4C (0.55) ALDH1A1KDRKDM4CKDM4EKDM6B
SCHEMBL2511447 0.79 KDM4C (0.78) ALDH1A1KDM4CKDM4EKDM6BKDM4A
SCHEMBL15542774 0.78 SMN1; SMN2 (0.52) ALDH1A1KDRKDM4EMAPTNAMPT
SCHEMBL27847518 0.78 KDM4C (0.67) ALDH1A1KDM4CKDM4EKDM6BKDM4A
SCHEMBL4977683 0.77 KDR (0.71) KDRFLT1NAMPTHTTKIT
SCHEMBL1523353 0.77 KDM4C (0.62) ALDH1A1KDM4CKDM4EKDM6BKDM4A
SCHEMBL16625628 0.77 KDR (0.84) ALDH1A1KDRKDM4EMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150099758-A1 Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof ANVYL LLC (US) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099758-A1 Alpha 7 Nicotinic Acetylcholine Receptor Allosteric Modulators, Their Derivatives and Uses Thereof CHRNA7, CHRNA1, CHRNA2 ALDH1A1 2093/4885KDR 4467/4885KDM4C 3149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.